Ashland pharmaceuticals

Visit us at CPHI Frankfurt 2025

show dates: October 28-30, 2025
location: Frankfurt, Germany
booth: 8.0Q48

Ashland’s team of solvers is excited to meet you at CPHI Frankfurt 2025 to showcase our latest products and innovations.

Discover Ashland’s comprehensive offering dedicated to injectables and biologics, including our viatel™ range for long-acting injectables, and let’s discuss our expanded portfolio of highly purified sugars with vialose™ trehalose dihydrate and the new vialose™ sucrose.

We will also showcase our new range of low nitrite excipients for oral solid dosage forms, including the latest additions to our portfolio, plasdone™ low nitrite povidone and benecel™ low nitrite hypromellose. Join us to explore strategies to mitigate nitrosamine formation and discover how our new excipients can support your formulation challenges.

When you're ready to formulate, we're ready to work with you.

Visit us to learn more about the ways we are always solvingTM.

  

Ashland offers a broad selection of pharmaceutical excipients to formulate effective pharmaceutical products. Well-kown for our cellulosics and acetylenics, Ashland also offers film coating solutions and an expanded portfolio for injectables and biologics.
The robust Ashland pharmaceutical portfolio includes immediate and controlled release excipients, film coating systems, bioresorbable polymers for long-acting injectables and lyoprotectants—supporting many of your formulation needs.

key products

  • vialose™ sucrose is a premier performance sugar used in biologic medicines to stabilize proteins and act as a lyoprotectant. Ashland offers exceedingly high purity sucrose to protect and shield biological molecules in biologic formulations. Vialose™ sucrose is tested to meet very low levels of endotoxins (<0.2 g/EU) and meets NF, EP, JP, BP and ChP monograph specifications.
     
  • viatel™ bioresorbable polymers are the building blocks for developing long-acting injectable depots, an established technology to improve therapeutic efficacy and patient compliance. All viatel™ bioresorbable polymers can be custom produced for a tailored solution.
     
  • plasdone™ low nitrite povidone, polyplasdone™ low nitrite crospovidone and benecel™ low nitrite hypromellose are our established excipients that now include a nitrite specification, with the nitrite level clearly reported on each CoA, helping you mitigate nitrosamine formation in your final drug product.​
     
  • aquarius™ coating systems are fully formulated systems available in a broad range of functionality, colors and are also offered in TiO2-free versions. Our coatings can be customized to achieve specific properties, depending on your formulation requirements.

 

lower left image

 

 

lower left image

 

contact us

Fill out the form below and we'll contact you to arrange a meeting.

By checking the subscribe box and submitting this form, I agree to my email address being stored and used to receive promotional emails from Ashland, and I acknowledge that I have read and understand the Ashland privacy policy.

related links